Lenalidomide Mylan

Medicinal product

(Invented) name

Lenalidomide Mylan

Active substance (s)

Lenalidomidas

Strength

7,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Mylan Pharmaceuticals Limited, Airija

Date of authorisation

2020-12-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Hard capsule	1 vnt.
Lenalidomidas	7,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105606	91706	1091706	lizdinė plokštelė	N7		Receptinis	EU/1/20/1490/006	Netiekiama	-	-	No	-	-
105607	91707	1091707	lizdinė plokštelė	N21		Receptinis	EU/1/20/1490/007	Netiekiama	-	-	No	-	-
105608	91708	1091708	dalomoji lizdinė plokštelė	N21×1		Receptinis	EU/1/20/1490/008	Netiekiama	-	-	No	-	-
106915	93018	1093018	dalomoji lizdinė plokštelė	N7×1		Receptinis	EU/1/20/1490/021	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-18	Registruotas